Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Greening Bone Healing: The Emerging Role of Plant-Derived Exosome-Like Nanoparticles in Osteoporosis and Osteoarthritis Therapy

Yuan S., He DW., Zhou XJ., Jiao HT., Gao Y., Li C.

Narrative Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41858571
PMCID
PMC12998583
DOI
10.2147/ijn.s569552

Abstract (original English)

Plant-derived exosome-like nanoparticles (PDENs) have demonstrated unique advantages in the prevention and treatment of osteoporosis and osteoarthritis in recent years. This review systematically summarizes the biological properties of PDENs, methods for their isolation and purification, molecular composition, and their mechanisms of action in bone and joint tissue repair. Current evidence indicates that PDENs can maintain bone homeostasis by promoting the proliferation and differentiation of osteoblasts, inhibiting osteoclast activity, modulating osteogenic differentiation of mesenchymal stem cells, and stimulating angiogenesis. In the context of osteoarthritis, PDENs enhance joint repair by facilitating chondrocyte regeneration, modulating inflammatory responses, and improving extracellular matrix metabolism. Despite the promising therapeutic potential of PDENs in the treatment of bone- and joint-related diseases, challenges remain regarding their precise mechanisms of action, standardization of preparation, and clinical translation. Future research should focus on elucidating the underlying mechanisms, establishing robust quality control methodologies, and conducting comprehensive preclinical evaluations to pave the way for their clinical application.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansOsteoporosisOsteoarthritisOsteogenesisNanoparticlesExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research